These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34873852)

  • 1. Circulating tumor cell count: A reliable biomarker for treatment selection in metastatic breast cancer.
    Li B; Zheng Y
    Thorac Cancer; 2022 Jan; 13(2):265-266. PubMed ID: 34873852
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.
    Somlo G; Lau SK; Frankel P; Hsieh HB; Liu X; Yang L; Krivacic R; Bruce RH
    Breast Cancer Res Treat; 2011 Jul; 128(1):155-63. PubMed ID: 21499685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Tumor Cells in Breast Cancer.
    Liang DH; Hall C; Lucci A
    Recent Results Cancer Res; 2020; 215():127-145. PubMed ID: 31605227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.
    Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS
    Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells: clinical validity and utility.
    Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
    Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer.
    Stefanovic S; Deutsch TM; Riethdorf S; Fischer C; Hartkopf A; Sinn P; Feisst M; Pantel K; Golatta M; Brucker SY; Sütterlin M; Schneeweiss A; Wallwiener M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers characterization of circulating tumour cells in breast cancer patients.
    Nadal R; Fernandez A; Sanchez-Rovira P; Salido M; Rodríguez M; García-Puche JL; Macià M; Corominas JM; Delgado-Rodriguez M; Gonzalez L; Albanell J; Fernández M; Solé F; Lorente JA; Serrano MJ
    Breast Cancer Res; 2012 May; 14(3):R71. PubMed ID: 22554015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients.
    Krawczyk N; Meier-Stiegen F; Banys M; Neubauer H; Ruckhaeberle E; Fehm T
    Biomed Res Int; 2014; 2014():415721. PubMed ID: 24895575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
    Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies?
    Dawood S; Cristofanilli M
    Pharmacogenomics; 2015; 16(7):669-72. PubMed ID: 25950463
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible applications of circulating tumor cells in patients with non small cell lung cancer.
    Tartarone A; Rossi E; Lerose R; Mambella G; Calderone G; Zamarchi R; Aieta M
    Lung Cancer; 2017 May; 107():59-64. PubMed ID: 27339469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of putative metastatic precursor cells in cancer patients.
    Alix-Panabières C; Vendrell JP; Pellé O; Rebillard X; Riethdorf S; Müller V; Fabbro M; Pantel K
    Clin Chem; 2007 Mar; 53(3):537-9. PubMed ID: 17327507
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic and predictive biomarkers in breast cancer: Past, present and future.
    Nicolini A; Ferrari P; Duffy MJ
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):56-73. PubMed ID: 28882552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.
    Wallwiener M; Hartkopf AD; Riethdorf S; Nees J; Sprick MR; Schönfisch B; Taran FA; Heil J; Sohn C; Pantel K; Trumpp A; Schneeweiss A
    BMC Cancer; 2015 May; 15():403. PubMed ID: 25972110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Relevance and Therapeutic Application of CTCs in Advanced Breast Cancer.
    Cueva Bañuelos JF; Rodríguez López C; Cortegoso Mosquera A; Palacios Ozores P; Curiel García T
    Adv Exp Med Biol; 2020; 1220():147-164. PubMed ID: 32304085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid Biopsy in Metastasized Breast Cancer as Basis for Treatment Decisions.
    Krawczyk N; Fehm T; Banys-Paluchowski M; Janni W; Schramm A
    Oncol Res Treat; 2016; 39(3):112-6. PubMed ID: 27031542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
    Gennari A; Foca F; Zamarchi R; Rocca A; Amadori D; De Censi A; Bologna A; Cavanna L; Gianni L; Scaltriti L; Rossi E; Facchinetti A; Martini V; Bruzzi P; Nanni O
    Breast Cancer Res Treat; 2020 May; 181(1):61-68. PubMed ID: 32200486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer.
    Nanou A; Zeune LL; Bidard FC; Pierga JY; Terstappen LWMM
    Breast Cancer Res; 2020 Aug; 22(1):86. PubMed ID: 32787900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
    Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
    Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.